Design of High-Specificity Nanocarriers by Exploiting Non-Equilibrium Effects in Cancer Cell Targeting.
Although targeting of cancer cells using drug-delivering nanocarriers holds promise for improving therapeutic agent specificity, the strategy of maximizing ligand affinity for receptors overexpressed on cancer cells is suboptimal. To determine design principles that maximize nanocarrier specificity...
Main Authors: | Konstantinos Tsekouras, Igor Goncharenko, Michael E Colvin, Kerwyn Casey Huang, Ajay Gopinathan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3694107?pdf=render |
Similar Items
-
Nanocarrier Design for Dual-Targeted Therapy of In-Stent Restenosis
by: Ivan S. Alferiev, et al.
Published: (2024-01-01) -
Targeting the Gut: A Systematic Review of Specific Drug Nanocarriers
by: Patrizia Garbati, et al.
Published: (2024-03-01) -
Challenges in the Therapeutic Exploitation of Chemokine Receptor-Mediated Internalization of Nanocarriers
by: Giuseppe Bardi
Published: (2024-10-01) -
Exploiting Lipid and Polymer Nanocarriers to Improve the Anticancer Sonodynamic Activity of Chlorophyll
by: Federica Bosca, et al.
Published: (2020-06-01) -
Nanocarriers targeting senescent cells
by: Daniel Muñoz-Espín
Published: (2019-01-01)